268 related articles for article (PubMed ID: 16311689)
1. [Consensus: Rational approach towards the patient with cancer, fever and neutropenia].
Santolaya ME; Rabagliati R; Bidart T; Payá E; Guzmán AM; Morales R; Braun S; Bronfman L; Ferrés M; Flores C; García P; Letelier LM; Puga B; Salgado C; Thompson L; Tordecilla J; Zubieta M; ;
Rev Chilena Infectol; 2005; 22 Suppl 2():S79-113. PubMed ID: 16311689
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the epidemiology of infections in patients with febrile neutropenia].
Karthaus M; Carratala J
Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
4. [Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].
Santolaya ME
Rev Med Chil; 2001 Dec; 129(12):1449-54. PubMed ID: 12080883
[TBL] [Abstract][Full Text] [Related]
5. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic procedures and management of Fever in pediatric cancer patients].
Laws HJ; Ammann RA; Lehrnbecher T
Klin Padiatr; 2005 Nov; 217 Suppl 1():S9-16. PubMed ID: 16288350
[TBL] [Abstract][Full Text] [Related]
7. Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
Timmer-Bonte JN; Adang EM; Termeer E; Severens JL; Tjan-Heijnen VC
J Clin Oncol; 2008 Jan; 26(2):290-6. PubMed ID: 18182670
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Luethy AR; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2007 Jul; 49(1):11-6. PubMed ID: 17143875
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
[TBL] [Abstract][Full Text] [Related]
10. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
[TBL] [Abstract][Full Text] [Related]
11. Supportive care in children.
Santolaya ME
Curr Opin Oncol; 2010 Jul; 22(4):323-9. PubMed ID: 20520543
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
te Poele EM; Tissing WJ; Kamps WA; de Bont ES
Crit Rev Oncol Hematol; 2009 Oct; 72(1):45-55. PubMed ID: 19195908
[TBL] [Abstract][Full Text] [Related]
13. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Ritchie S; Palmer S; Ellis-Pegler R
Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
[TBL] [Abstract][Full Text] [Related]
14. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.
Kearney N; Friese C
Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of febrile neutropenia in patients with solid tumors].
Novotný J; Petruzelka L; Jedlicková A; Mikolásová B
Cas Lek Cesk; 1998 Nov; 137(22):694-9. PubMed ID: 9929937
[TBL] [Abstract][Full Text] [Related]
17. [Invasive fungal infections in children with cancer, neutropenia and fever, in Chile].
Lucero Y; Brücher R; Alvarez AM; Becker A; Cofré J; Enríquez N; Payá E; Salgado C; Santolaya ME; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; O'Ryan M
Rev Med Chil; 2002 Oct; 130(10):1139-46. PubMed ID: 12491831
[TBL] [Abstract][Full Text] [Related]
18. Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.
Donohue R
Oncol Nurs Forum; 2006 Nov; 33(2):347-52. PubMed ID: 16518450
[TBL] [Abstract][Full Text] [Related]
19. Outpatient management of febrile neutropenia: time to revise the present treatment strategy.
Carstensen M; Sørensen JB
J Support Oncol; 2008; 6(5):199-208. PubMed ID: 18551855
[TBL] [Abstract][Full Text] [Related]
20. The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting.
Tuffaha HW; Treish IM; Zaru L
J Oncol Pharm Pract; 2008 Sep; 14(3):131-8. PubMed ID: 18524866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
